|1.||Brady-Kalnay, Susann M: 8 articles (09/2014 - 03/2002)|
|2.||Burden-Gulley, Susan M: 5 articles (04/2013 - 03/2002)|
|3.||Chan, Timothy A: 3 articles (01/2015 - 06/2009)|
|4.||Phillips-Mason, Polly J: 3 articles (09/2014 - 09/2009)|
|5.||Leigh, Irene M: 3 articles (08/2012 - 07/2007)|
|6.||Proby, Charlotte M: 3 articles (08/2012 - 07/2007)|
|7.||Lambert, Sally R: 3 articles (08/2012 - 07/2007)|
|8.||Harwood, Catherine A: 3 articles (08/2012 - 07/2007)|
|9.||Purdie, Karin J: 3 articles (08/2012 - 07/2007)|
|10.||Robinson, Shenandoah: 3 articles (04/2010 - 09/2009)|
04/01/2015 - "PTPRD (protein tyrosine phosphatase, receptor type, D) is a tumor suppressor gene, frequently inactivated through deletions or epigenetic mechanisms in several cancers with importance for global health. "
08/30/2014 - "PTPRD encodes the protein tyrosine phosphatase receptor type D and is frequently inactivated across many human cancers. "
06/01/2013 - "Protein tyrosine phosphatase delta (PTPRD) is a tumor suppressor that inhibits STAT3 activation. "
04/01/2013 - "The PTPmu probe has potential translational significance for recognizing tumor cells to facilitate molecular imaging, a more complete tumor resection and to serve as a molecular targeting agent to deliver chemotherapeutics to the main tumor mass and distant dispersive tumor cells."
04/01/2013 - "Our data demonstrate that the PTPmu probe recognizes distant tumor cells even in parts of the brain where the blood-brain barrier is likely intact. "
01/01/2013 - "In particular, protein tyrosine phosphatase, receptor type, F (PTPRF) may serve as a biomarker linking insulin resistance with insufficient milk supply. "
03/01/2012 - " Five single nucleotide polymorphisms (SNPs) near the protein tyrosine phosphatase, receptor type, D (PTPRD), SRR, MAF/WWOX, and KCNQ1 genes were genotyped in 1138 subjects of Chinese origin from the Stanford Asia-Pacific Program for Hypertension and Insulin Resistance study. "
|3.||Astrocytoma (Pilocytic Astrocytoma)
12/01/2009 - "These studies revealed a striking loss of PTPmu protein expression in highly dispersive GBMs compared to less dispersive low-grade astrocytomas and normal brain. "
12/01/2009 - "PTPmu expression was examined in human GBM, low-grade astrocytoma, and normal brain tissue. "
04/01/2010 - "We recently found that normal human brain and low-grade astrocytomas express the receptor protein tyrosine phosphatase mu (PTPmu) and that the more invasive astrocytomas, glioblastoma multiforme (GBM), downregulate full-length PTPmu expression. "
|4.||Colorectal Neoplasms (Colorectal Cancer)
|3.||Carrier Proteins (Binding Protein)
|4.||GTP-Binding Proteins (G-Protein)
|5.||Insulin-Like Growth Factor Binding Protein 5
|6.||Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)
|9.||aldehyde dehydrogenase 1
|1.||Heterologous Transplantation (Xenotransplantation)